Exercise limitation in patients with interstitial lung disease independent from diffusion capacity (DLCO) Source: Annual Congress 2008 - Exercise: system responses Year: 2008
Lung Clearance Index (LCI) and diffusion capacity of the lung (DLCO) in children with rheumatic disease Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases Year: 2020
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007
Blood gas parameters at exercise are more sensitive for lung involvement in patients with SSc than DLCO Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010
Static lung compliance (Cst) and diffusion lung capacity (DLCO) as markers of lung function impairment in sarcoid patients with normal lung volumes Source: Eur Respir J 2003; 22: Suppl. 45, 278s Year: 2003
Respiratory function in systemic sclerosis patients Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015
CT scan derived emphysema scores correlate with spirometry and gas exchange but not acute exacerbation rates (AER) or COPD assessment test (CAT) in COPD subjects with and without alpha-1-antitrypsin (AAT) deficiency Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
The EDD (exercise, DLco, dyspnea) index in diffuse systemic sclerosis with pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
Interstitial lung disease (ILD) in juvenile systemic sclerosis (JSS): correlation between high-resolution computed tomography (HRCT) and pulmonary function test (PFT) changes Source: Annual Congress 2008 - Miscellaneous respiratory infections Year: 2008
Comparison of ventilation heterogeneity (VH) measured with multiple breath washout (MBW) imaging to whole lung MBW LCI and FEV1 in asthma and cystic fibrosis (CF) Source: International Congress 2015 – Functional imaging approaches for evaluating alteration of lung, airways and respiratory muscles Year: 2015
Lung function testing (LFT), diffusing capacity (DC) in patients with rheumatologic disorders: Is spirometry exclusionary? Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011
Adherence rates to 2005 ATS/ERS test performance standards for spirometry, single-breath diffusing capacity (DLco), and lung volumes in a multi-center inhaled insulin study Source: Annual Congress 2008 - Beyond spirometry: the skills behind lung function testing Year: 2008
Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD Source: International Congress 2015 – COPD: notable points Year: 2015
Effects of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) and differing FVC at baseline: the SENSCIS trial Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new? Year: 2019
The role of spirometry and ?arbon monoxide diffusing capacity (DLCO) in the diagnosis of pulmonary function in patients after COVID-19 pneumonia Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era Year: 2021
Outcome differences between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) - data from the EXCITING registry Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018
Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion and resistance Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013
Changes in FVC in the SENSCIS trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD) Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension Year: 2019
Assessment of disease progression in systemic sclerosis-associated interstitial lung disease (SSc-ILD) patients using Functional Respiratory Imaging (FRI) Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update Year: 2019
Functional disorders in patients with COPD assessed by spirometry DLCO transfer characteristics, and plethysmography Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014